Alexandria Real Estate Equities, Inc. - Jun 4, 2024 Form 4 Insider Report for Applied Therapeutics, Inc. (APLT)

Role
10%+ Owner
Signature
ALEXANDRIA REAL ESTATE EQUITIES, INC., By: /s/ Marc E. Binda, Chief Financial Officer and Treasurer
Stock symbol
APLT
Transactions as of
Jun 4, 2024
Transactions value $
-$1,267,500
Form type
4
Date filed
6/6/2024, 06:45 PM
Previous filing
Dec 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Sale -$632K -150K -2.44% $4.21 6.01M Jun 4, 2024 By subsidiary F1, F2
transaction APLT Common Stock Sale -$636K -150K -2.5% $4.24 5.86M Jun 5, 2024 By subsidiary F2, F3
holding APLT Common Stock 204K Jun 4, 2024 By subsidiary F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $4.12 to $4.32. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 These securities are held directly by Alexandria Venture Investments, LLC, an affiliate of Alexandria Equities No. 7, LLC ("AE7"), and a wholly owned subsidiary of Alexandria Real Estate Equities, Inc.
F3 The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $4.10 to $4.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 These securities are held directly by AE7, a wholly owned subsidiary of Alexandria Real Estate Equities, Inc.